BFSG, LLC

Position in NVS — Novartis AG

CIK 1706836 IRVINE, CA

Position in NVS

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$115,816

+$8,891 QoQ

Shares Held

739

+5.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#1,361

of 1,603 holders

Holding Since

Mar 2020

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

BFSG, LLC holds $27,089,521 across 12 Drug Manufacturers - General names. NVS ranks #10 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	22,116	$5,565,270
2	JNJ	Johnson & Johnson	21,466	$5,451,720
3	AMGN	Amgen Inc	13,879	$5,025,863
4	MRK	Merck & Co., Inc.	35,943	$4,618,675
5	LLY	ELI LILLY & Co	3,326	$3,989,304
6	PFE	Pfizer Inc	50,722	$1,221,385
7	NVO	Novo Nordisk A S	12,243	$586,929
8	OGN	Organon & Co.	29,058	$393,445

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$115,816	739	+5.6%	Shares	Sole	2026-07-20
2026-03-31	$106,925	700	-6.7%	Shares	Sole	2026-04-29
2025-12-31	$103,402	750	+7.9%	Shares	Sole	2026-01-22
2025-09-30	$89,126	695	+1.3%	Shares	Sole	2025-10-29
2025-06-30	$83,012	686	+0.4%	Shares	Sole	2025-07-15
2025-03-31	$76,140	683	+1.9%	Shares	Sole	2025-04-18
2024-12-31	$65,197	670	-33.0%	Shares	Sole	2025-01-31
2024-09-30	$115,020	1,000	-1.2%	Shares	Sole	2024-10-16
2024-06-30	$107,737	1,012	+1.0%	Shares	Sole	2024-07-29
2024-03-31	$96,923	1,002	+4.2%	Shares	Sole	2024-04-23
2023-12-31	$97,133	962	-66.7%	Shares	Sole	2024-04-23
2021-12-31	$252,350	2,885	-26.8%	Shares	Sole	2022-01-24
2021-09-30	$322,213	3,940	-20.1%	Shares	Sole	2021-11-03
2021-03-31	$421,416	4,930	-38.5%	Shares	Sole	2021-04-26
2020-12-31	$757,328	8,020	+2.9%	Shares	Sole	2021-01-26
2020-09-30	$677,853	7,795	+11.8%	Shares	Sole	2020-11-04
2020-06-30	$609,196	6,975	-4.5%	Shares	Sole	2020-07-22
2020-03-31	$602,297	7,305	—	Shares	Sole	2020-04-27
No filing history on record for this holder in this stock.